| Insider | Abel Robert Lorne |
|---|---|
| Title | EVP, Chief Scientific Officer, Platform |
| Transaction Date | Mar 2, 2026 |
| Expiration Date | Mar 2, 2036 |
| Transaction Code | A Grant/Award |
| Acquired/Disposed | Acquired |
| Security | Stock Option (right to buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Mar 3, 2026 |
| Shares Purchased | 34,250 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 34,250 |
| Derivative | Derivative |
| Accession Number | 0001798179-26-000004 |
| Document | View SEC Filing |